Medtronic’s MiniMed 780G System sets new standards in diabetes management
Medtronic plc (NYSE: MDT), a global frontrunner in medical technology, has recently unveiled compelling new clinical and real-world evidence regarding the MiniMed 780G system, marking a significant advancement in diabetes management technology. Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Florence, Italy, this evidence underscores the system’s efficacy […]